-
Yizekang (Izalontamab Brengitecan) – NPC/ESCC
- Generic Name/Brand Name: Izalontamab Brengitecan/Yizekang
- Indications: Recurrent or metastatic nasopharyngeal carcinoma (NPC); Recurrent or metastatic esophageal squamous cell carcinoma (ESCC)
- Dosage Form: Injection
- Specification: 120 mg/vial
Close
